HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma

por Huang, Fu-xue, Wu, Jun-wan, Cheng, Xia-qin, Wang, Jiu-hong, Wen, Xi-zhi, Li, Jing-jing, Zhang, Qiong, Jiang, Hang, Ding, Qiu-yue, Zhu, Xiao-feng, Zhang, Xiao-shi, Ding, Ya, Li, Dan-dan
Publicado 2022

Loss of HRD functional phenotype impedes immunotherapy and can be reversed by HDAC inhibitor in ovarian cancer

por Yang, Dong, Huang, Fu-Xue, Wei, Wei, Li, Qia-Qia, Wu, Jun-Wan, Huang, Yun, Li, Zhi-Ling, Zhang, Hai-Liang, Li, Xuan, Yuan, Qiu-Er, Chen, Qing-shan, Feng, Gong-kan, Rong, Deng, Li, Jun-Dong, Zhu, Xiao-Feng
Publicado 2023